CVRx, Inc. — Director's Dealing 2022

Jan 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2022-01-18

Reporting Person: Galle Liz (VP of Global Clinical Research)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-18	Stock Option (right to buy)	$9.08	A	25900	Acquired	2032-01-17	Common Stock (25900)	Direct

Footnotes

F1: Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter.